MENU
RPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Royalty Pharma (RPRX) Ownership - Who owns Royalty Pharma?

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties... Show more

Profile

Industry
Pharmaceuticals Major
Address
110 East 59th Street
Phone
+1 212 883-0200
Employees
89
Web
https://www.royaltypharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.77B
P/E Ratio
22.43
Total Cash
1.82B
Projected Growth
1.73
Total Debt
8.95B
Revenue
2.35B
Risk (Beta)
0.76
Dividend Yield
0.02
Total Cash/Share
4.25
Total Debt/Equity
N/A
Revenue/Share
4.11 USD as % of share price

Fundamentals

RPRX
Capitalization
16.8B
P/E Ratio
22.43
Risk (Beta)
0.76
Dividend Yield
0.02
Total Cash
1.82B
Total Cash/Share
4.25
Total Debt
8.95B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
1.73
Revenue/Share (as % of the share price)
4.11%
Revenue
2.35B
ROE
N/A
Book Value
6.41B
P/B Ratio
2.61
Cash Flow
N/A
Earnings
1.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
107K
Current Ratio
3.48
Current Revenue Per Employee
6154454.50
Dividends Per Share - Security
0.22
EBITDA
1.59B
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
4.09
Shares Held By Institutions
29.6B
Shares Outstanding - Current
427M
Total Liabilities
9.73B
Total Volume MTD
N/A
Value
1
Gain YTD
56.865
View a ticker or compare two or three
RPRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RPRX showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of drug development services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
110 East 59th Street
Phone
+1 212 883-0200
Employees
89
Web
https://www.royaltypharma.com